您当前的位置:检测资讯 > 其他

日本关于药品、医疗器械、再生细胞治疗产品、基因治疗产品和化妆品质量保证、功效和安全的法案规定

嘉峪检测网        2015-09-17 22:28

通报号: G/TBT/N/JPN/486
ICS号: 11
发布日期: 2015-05-11
截至日期: 2015-05-11
通报成员: 日本
目标和理由: 产品或技术安全要求
内容概述: 药事法规定的指定物质(827种指定物质:这些物质具有共同的化学结构,1-苯基-1-丙酮为基本框架)及其“正确用途”提案。
正文: 
世界贸易组织
G/TBT/N/JPN/486
2015-05-11
15-2471
 
技术性贸易壁垒
原文:英语
 
通 报


以下通报根据TBT协定第10.6条分发

1.
通报成员: 日本
如可能,列出涉及的地方政府名称 ( 3.2条和7.2 条):
2.
负责机构:厚生劳动省(MHLW)
3.
通报依据条款:2.10.1
4.
覆盖的产品: 可能影响中枢神经系统的物质
HS编码:9802   ICS编码:11
5.
通报标题: 指定物质,基于关于药品、医疗器械、再生细胞治疗产品、基因治疗产品和化妆品质量保证、功效和安全的法案规定(以下称为“法案”)(1960,法案No.145)

语言:英语 页数:1 链接网址:
 
6.
内容简述: 药事法规定的指定物质(827种指定物质:这些物质具有共同的化学结构,1-苯基-1-丙酮为基本框架)及其“正确用途”提案。
7.
目标与理由:为防止滥用可能影响中枢神经系统的物质,及依照药事法澄清法规,厚生劳动省(MHLW)指定此类物质为“指定物质”。禁止生产、进口、销售、拥有及使用“指定物质”,除依照药事法规定的“正确用途”以外。保护人类健康。
8.
相关文件: 批准时指定物质及其正确用途公布在官方公报上
9.
拟批准日期:2015/05/01
拟生效日期:2015/05/11
10.
意见反馈截止日期: 不适用
11.
文本可从以下机构得到:

正文(英): 

NOTIFICATION

The following notification is being circulated in accordance with Article 10.6

 

1.

Notifying Member: Japan

If applicable, name of local government involved (Article 3.2 and 7.2):  

2.

Agency responsible: Ministry of Health, Labour and Welfare (MHLW)

Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:  

3.

Notified under Article 2.9.2 [   ], 2.10.1 [ X ], 5.6.2 [   ], 5.7.1 [   ], other:

4.

Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Substances with probable effects on the central nervous system

5.

Title, number of pages and language(s) of the notified document: Designation of "Shitei Yakubutsu" (designated substances), based on the provision of the Act on Securing Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics (hereinafter referred to as the "Act"). (1960, Law No.145) (1 pages, in English).

6.

Description of content: Proposed "Shitei Yakubutsu" (designated 827 substances: All of these substances have a common chemical structure, 1-Phenyl-propan-1-one, as the basic frame.), and their "proper uses" designated under the Act.

7.

Objective and rationale, including the nature of urgent problems where applicable:

In order to prevent the abuse of substances with probable effects on the central nervous system and to clarify the regulation under the Act, the MHLW designates such substances as "Shitei Yakubutsu" Manufacture, import and sale, simple ownership and the use of "Shitei Yakubutsu" are banned except for the "proper uses" designated under the Act. Protection of human health.

8.

Relevant documents: When adopted, "Shitei Yakubutsu" (designated substances) and their proper uses will be publicized in the Official Gazette, "KAMPO".

9.

Proposed date of adoption: 1 May 2015  

Proposed date of entry into force: 11 May 2015

10.

Final date for comments: Not applicable

11.

Texts available from: National enquiry point [ X] or address, telephone and fax numbers and email and website addresses, if available, of other body:

Japan Enquiry Point

International Trade Division, Economic Affairs Bureau, Ministry of Foreign Affairs

Fax: (+81 3) 5501 8343

E-mail: enquiry@mofa.go.jp

https://members.wto.org/crnattachments/2015/TBT/JPN/15_1918_00_e.pdf

 

本网维权及免责声明:

      ①凡本网所有原始/编译文章及图片、图表的版权均属江苏省技术性贸易措施信息平台(www.tbtguide.com)所有,如要转载,需注明"信息来源:江苏省技术性贸易措施信息平台"或"信息来源:tbtguide"。违反上述规定者,本网将保留追究其侵权责任的权利。

      ②凡本网注明"信息来源:XXX(非tbtguide)"的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。

      联系E-mail:js_wto@163.com

分享到:

来源:未知

相关新闻: